Inclusion body myositis: The interplay between ageing, muscle degeneration and autoimmunity Article Swipe
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1016/j.berh.2022.101761
Inclusion body myositis (IBM) is a slowly progressive muscle disease affecting ageing individuals. IBM presents with a distinctive pattern of weakness involving the quadriceps and finger flexor muscles, although other muscles including pharyngeal muscles become affected over time. Pathological hallmarks of IBM include autoimmune features, including endomysial infiltration by highly differentiated T cells, as well as degenerative features marked by intramyofibre protein aggregates organised into inclusion bodies. Despite some progress in understanding the cellular pathways involved in IBM, it remains untreatable, and the progression of the disease leads to progressive weakness, disability, wheelchair dependency and loss of independence. Therefore, there is an urgent need to improve our understanding of the underlying mechanisms and pathways involved in this disease to identify new treatment targets. Here, we discuss the current understanding of aetiopathogenesis, the interrelationship between autoimmunity and degeneration, and how ageing is a major influencer of both these features.
Related Topics
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.berh.2022.101761
- OA Status
- hybrid
- Cited By
- 18
- References
- 102
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4283463193
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4283463193Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.berh.2022.101761Digital Object Identifier
- Title
-
Inclusion body myositis: The interplay between ageing, muscle degeneration and autoimmunityWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-06-01Full publication date if available
- Authors
-
Emily McLeish, Nataliya Slater, Anuradha Sooda, Andrew D. Wilson, Jérôme D. Coudert, Thomas E. Lloyd, Merrilee NeedhamList of authors in order
- Landing page
-
https://doi.org/10.1016/j.berh.2022.101761Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.berh.2022.101761Direct OA link when available
- Concepts
-
Inclusion body myositis, Medicine, Degeneration (medical), Myositis, Autoimmunity, Ageing, Weakness, Muscle weakness, Disease, Sarcopenia, Neuroscience, Physical medicine and rehabilitation, Pathology, Anatomy, Biology, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
18Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 5, 2024: 10, 2023: 3Per-year citation counts (last 5 years)
- References (count)
-
102Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4283463193 |
|---|---|
| doi | https://doi.org/10.1016/j.berh.2022.101761 |
| ids.doi | https://doi.org/10.1016/j.berh.2022.101761 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/35760741 |
| ids.openalex | https://openalex.org/W4283463193 |
| fwci | 4.03958895 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000375 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Aging |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D015551 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Autoimmunity |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D006801 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Humans |
| mesh[3].qualifier_ui | Q000473 |
| mesh[3].descriptor_ui | D009132 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | pathology |
| mesh[3].descriptor_name | Muscles |
| mesh[4].qualifier_ui | Q000150 |
| mesh[4].descriptor_ui | D009220 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | complications |
| mesh[4].descriptor_name | Myositis |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D018979 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Myositis, Inclusion Body |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D066329 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Protein Aggregates |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000375 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Aging |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D015551 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Autoimmunity |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D006801 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Humans |
| mesh[10].qualifier_ui | Q000473 |
| mesh[10].descriptor_ui | D009132 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | pathology |
| mesh[10].descriptor_name | Muscles |
| mesh[11].qualifier_ui | Q000150 |
| mesh[11].descriptor_ui | D009220 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | complications |
| mesh[11].descriptor_name | Myositis |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D018979 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Myositis, Inclusion Body |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D066329 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Protein Aggregates |
| type | review |
| title | Inclusion body myositis: The interplay between ageing, muscle degeneration and autoimmunity |
| biblio.issue | 2 |
| biblio.volume | 36 |
| biblio.last_page | 101761 |
| biblio.first_page | 101761 |
| topics[0].id | https://openalex.org/T11724 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Inflammatory Myopathies and Dermatomyositis |
| topics[1].id | https://openalex.org/T12600 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9965999722480774 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2745 |
| topics[1].subfield.display_name | Rheumatology |
| topics[1].display_name | Eosinophilic Disorders and Syndromes |
| topics[2].id | https://openalex.org/T11348 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9934999942779541 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2715 |
| topics[2].subfield.display_name | Gastroenterology |
| topics[2].display_name | Celiac Disease Research and Management |
| funders[0].id | https://openalex.org/F4320330217 |
| funders[0].ror | https://ror.org/04yn72m09 |
| funders[0].display_name | Perron Institute for Neurological and Translational Science |
| funders[1].id | https://openalex.org/F4320333282 |
| funders[1].ror | |
| funders[1].display_name | School of Medicine, Johns Hopkins University |
| is_xpac | False |
| apc_list.value | 3720 |
| apc_list.currency | USD |
| apc_list.value_usd | 3720 |
| apc_paid.value | 3720 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3720 |
| concepts[0].id | https://openalex.org/C2777327098 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9301538467407227 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1848471 |
| concepts[0].display_name | Inclusion body myositis |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.790728747844696 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2779354088 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5770522356033325 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q15467261 |
| concepts[2].display_name | Degeneration (medical) |
| concepts[3].id | https://openalex.org/C2781232998 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5722174644470215 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1433212 |
| concepts[3].display_name | Myositis |
| concepts[4].id | https://openalex.org/C2780130043 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5721014142036438 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q192360 |
| concepts[4].display_name | Autoimmunity |
| concepts[5].id | https://openalex.org/C500499127 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5184866786003113 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q332154 |
| concepts[5].display_name | Ageing |
| concepts[6].id | https://openalex.org/C2780247198 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5181878209114075 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q633403 |
| concepts[6].display_name | Weakness |
| concepts[7].id | https://openalex.org/C2776418732 |
| concepts[7].level | 2 |
| concepts[7].score | 0.5117706656455994 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q270421 |
| concepts[7].display_name | Muscle weakness |
| concepts[8].id | https://openalex.org/C2779134260 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4833635687828064 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[8].display_name | Disease |
| concepts[9].id | https://openalex.org/C2776214593 |
| concepts[9].level | 2 |
| concepts[9].score | 0.43833082914352417 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1787939 |
| concepts[9].display_name | Sarcopenia |
| concepts[10].id | https://openalex.org/C169760540 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3943779468536377 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q207011 |
| concepts[10].display_name | Neuroscience |
| concepts[11].id | https://openalex.org/C99508421 |
| concepts[11].level | 1 |
| concepts[11].score | 0.39316248893737793 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q2678675 |
| concepts[11].display_name | Physical medicine and rehabilitation |
| concepts[12].id | https://openalex.org/C142724271 |
| concepts[12].level | 1 |
| concepts[12].score | 0.358081191778183 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[12].display_name | Pathology |
| concepts[13].id | https://openalex.org/C105702510 |
| concepts[13].level | 1 |
| concepts[13].score | 0.16970762610435486 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q514 |
| concepts[13].display_name | Anatomy |
| concepts[14].id | https://openalex.org/C86803240 |
| concepts[14].level | 0 |
| concepts[14].score | 0.10640653967857361 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[14].display_name | Biology |
| concepts[15].id | https://openalex.org/C126322002 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[15].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/inclusion-body-myositis |
| keywords[0].score | 0.9301538467407227 |
| keywords[0].display_name | Inclusion body myositis |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.790728747844696 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/degeneration |
| keywords[2].score | 0.5770522356033325 |
| keywords[2].display_name | Degeneration (medical) |
| keywords[3].id | https://openalex.org/keywords/myositis |
| keywords[3].score | 0.5722174644470215 |
| keywords[3].display_name | Myositis |
| keywords[4].id | https://openalex.org/keywords/autoimmunity |
| keywords[4].score | 0.5721014142036438 |
| keywords[4].display_name | Autoimmunity |
| keywords[5].id | https://openalex.org/keywords/ageing |
| keywords[5].score | 0.5184866786003113 |
| keywords[5].display_name | Ageing |
| keywords[6].id | https://openalex.org/keywords/weakness |
| keywords[6].score | 0.5181878209114075 |
| keywords[6].display_name | Weakness |
| keywords[7].id | https://openalex.org/keywords/muscle-weakness |
| keywords[7].score | 0.5117706656455994 |
| keywords[7].display_name | Muscle weakness |
| keywords[8].id | https://openalex.org/keywords/disease |
| keywords[8].score | 0.4833635687828064 |
| keywords[8].display_name | Disease |
| keywords[9].id | https://openalex.org/keywords/sarcopenia |
| keywords[9].score | 0.43833082914352417 |
| keywords[9].display_name | Sarcopenia |
| keywords[10].id | https://openalex.org/keywords/neuroscience |
| keywords[10].score | 0.3943779468536377 |
| keywords[10].display_name | Neuroscience |
| keywords[11].id | https://openalex.org/keywords/physical-medicine-and-rehabilitation |
| keywords[11].score | 0.39316248893737793 |
| keywords[11].display_name | Physical medicine and rehabilitation |
| keywords[12].id | https://openalex.org/keywords/pathology |
| keywords[12].score | 0.358081191778183 |
| keywords[12].display_name | Pathology |
| keywords[13].id | https://openalex.org/keywords/anatomy |
| keywords[13].score | 0.16970762610435486 |
| keywords[13].display_name | Anatomy |
| keywords[14].id | https://openalex.org/keywords/biology |
| keywords[14].score | 0.10640653967857361 |
| keywords[14].display_name | Biology |
| language | en |
| locations[0].id | doi:10.1016/j.berh.2022.101761 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S1036238847 |
| locations[0].source.issn | 1521-6942, 1532-1770 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1521-6942 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Best Practice & Research Clinical Rheumatology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_lineage_names | Elsevier BV |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Best Practice & Research Clinical Rheumatology |
| locations[0].landing_page_url | https://doi.org/10.1016/j.berh.2022.101761 |
| locations[1].id | pmid:35760741 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Best practice & research. Clinical rheumatology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/35760741 |
| locations[2].id | pmh:oai:HAL:hal-04870938v1 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306402512 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | HAL (Le Centre pour la Communication Scientifique Directe) |
| locations[2].source.host_organization | https://openalex.org/I1294671590 |
| locations[2].source.host_organization_name | Centre National de la Recherche Scientifique |
| locations[2].source.host_organization_lineage | https://openalex.org/I1294671590 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Journal articles |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Best Practice and Research: Clinical Rheumatology, 2022, 36, ⟨10.1016/j.berh.2022.101761⟩ |
| locations[2].landing_page_url | https://hal.science/hal-04870938 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5091086475 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6666-342X |
| authorships[0].author.display_name | Emily McLeish |
| authorships[0].countries | AU |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I176790772 |
| authorships[0].affiliations[0].raw_affiliation_string | Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia |
| authorships[0].institutions[0].id | https://openalex.org/I176790772 |
| authorships[0].institutions[0].ror | https://ror.org/00r4sry34 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I176790772 |
| authorships[0].institutions[0].country_code | AU |
| authorships[0].institutions[0].display_name | Murdoch University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | E. McLeish |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia |
| authorships[1].author.id | https://openalex.org/A5029909439 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-9979-6074 |
| authorships[1].author.display_name | Nataliya Slater |
| authorships[1].countries | AU |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I176790772 |
| authorships[1].affiliations[0].raw_affiliation_string | Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia |
| authorships[1].institutions[0].id | https://openalex.org/I176790772 |
| authorships[1].institutions[0].ror | https://ror.org/00r4sry34 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I176790772 |
| authorships[1].institutions[0].country_code | AU |
| authorships[1].institutions[0].display_name | Murdoch University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | N. Slater |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia |
| authorships[2].author.id | https://openalex.org/A5018961742 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-2576-3309 |
| authorships[2].author.display_name | Anuradha Sooda |
| authorships[2].countries | AU |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I176790772 |
| authorships[2].affiliations[0].raw_affiliation_string | Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia |
| authorships[2].institutions[0].id | https://openalex.org/I176790772 |
| authorships[2].institutions[0].ror | https://ror.org/00r4sry34 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I176790772 |
| authorships[2].institutions[0].country_code | AU |
| authorships[2].institutions[0].display_name | Murdoch University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | A. Sooda |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia |
| authorships[3].author.id | https://openalex.org/A5078791295 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5751-9354 |
| authorships[3].author.display_name | Andrew D. Wilson |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| authorships[3].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[3].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[3].institutions[1].id | https://openalex.org/I145311948 |
| authorships[3].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | Johns Hopkins University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | A. Wilson |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| authorships[4].author.id | https://openalex.org/A5074209785 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-6081-8494 |
| authorships[4].author.display_name | Jérôme D. Coudert |
| authorships[4].countries | AU |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210144648 |
| authorships[4].affiliations[0].raw_affiliation_string | Perron Institute for Neurological and Translational Science, Perth, WA, Australia |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I93396115 |
| authorships[4].affiliations[1].raw_affiliation_string | School of Medicine, University of Notre Dame, Fremantle, WA, Australia |
| authorships[4].affiliations[2].institution_ids | https://openalex.org/I176790772 |
| authorships[4].affiliations[2].raw_affiliation_string | Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia |
| authorships[4].institutions[0].id | https://openalex.org/I176790772 |
| authorships[4].institutions[0].ror | https://ror.org/00r4sry34 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I176790772 |
| authorships[4].institutions[0].country_code | AU |
| authorships[4].institutions[0].display_name | Murdoch University |
| authorships[4].institutions[1].id | https://openalex.org/I4210144648 |
| authorships[4].institutions[1].ror | https://ror.org/04yn72m09 |
| authorships[4].institutions[1].type | facility |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210144648 |
| authorships[4].institutions[1].country_code | AU |
| authorships[4].institutions[1].display_name | Perron Institute for Neurological and Translational Science |
| authorships[4].institutions[2].id | https://openalex.org/I93396115 |
| authorships[4].institutions[2].ror | https://ror.org/02stey378 |
| authorships[4].institutions[2].type | education |
| authorships[4].institutions[2].lineage | https://openalex.org/I93396115 |
| authorships[4].institutions[2].country_code | AU |
| authorships[4].institutions[2].display_name | The University of Notre Dame Australia |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | J.D. Coudert |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia, Perron Institute for Neurological and Translational Science, Perth, WA, Australia, School of Medicine, University of Notre Dame, Fremantle, WA, Australia |
| authorships[5].author.id | https://openalex.org/A5037255930 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4756-3700 |
| authorships[5].author.display_name | Thomas E. Lloyd |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| authorships[5].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[5].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[5].institutions[1].id | https://openalex.org/I145311948 |
| authorships[5].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[5].institutions[1].country_code | US |
| authorships[5].institutions[1].display_name | Johns Hopkins University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | T.E. Lloyd |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| authorships[6].author.id | https://openalex.org/A5051877073 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6591-1444 |
| authorships[6].author.display_name | Merrilee Needham |
| authorships[6].countries | AU |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210144648 |
| authorships[6].affiliations[0].raw_affiliation_string | Perron Institute for Neurological and Translational Science, Perth, WA, Australia |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I93396115 |
| authorships[6].affiliations[1].raw_affiliation_string | School of Medicine, University of Notre Dame, Fremantle, WA, Australia |
| authorships[6].affiliations[2].institution_ids | https://openalex.org/I2800728469 |
| authorships[6].affiliations[2].raw_affiliation_string | Fiona Stanley Hospital, Department of Neurology, Perth, WA, Australia |
| authorships[6].affiliations[3].institution_ids | https://openalex.org/I176790772 |
| authorships[6].affiliations[3].raw_affiliation_string | Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia |
| authorships[6].institutions[0].id | https://openalex.org/I2800728469 |
| authorships[6].institutions[0].ror | https://ror.org/027p0bm56 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2799506148, https://openalex.org/I2800728469, https://openalex.org/I2800882159, https://openalex.org/I4388446375, https://openalex.org/I4388482742 |
| authorships[6].institutions[0].country_code | AU |
| authorships[6].institutions[0].display_name | Fiona Stanley Hospital |
| authorships[6].institutions[1].id | https://openalex.org/I176790772 |
| authorships[6].institutions[1].ror | https://ror.org/00r4sry34 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I176790772 |
| authorships[6].institutions[1].country_code | AU |
| authorships[6].institutions[1].display_name | Murdoch University |
| authorships[6].institutions[2].id | https://openalex.org/I4210144648 |
| authorships[6].institutions[2].ror | https://ror.org/04yn72m09 |
| authorships[6].institutions[2].type | facility |
| authorships[6].institutions[2].lineage | https://openalex.org/I4210144648 |
| authorships[6].institutions[2].country_code | AU |
| authorships[6].institutions[2].display_name | Perron Institute for Neurological and Translational Science |
| authorships[6].institutions[3].id | https://openalex.org/I93396115 |
| authorships[6].institutions[3].ror | https://ror.org/02stey378 |
| authorships[6].institutions[3].type | education |
| authorships[6].institutions[3].lineage | https://openalex.org/I93396115 |
| authorships[6].institutions[3].country_code | AU |
| authorships[6].institutions[3].display_name | The University of Notre Dame Australia |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | M. Needham |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia, Fiona Stanley Hospital, Department of Neurology, Perth, WA, Australia, Perron Institute for Neurological and Translational Science, Perth, WA, Australia, School of Medicine, University of Notre Dame, Fremantle, WA, Australia |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.berh.2022.101761 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Inclusion body myositis: The interplay between ageing, muscle degeneration and autoimmunity |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11724 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Inflammatory Myopathies and Dermatomyositis |
| related_works | https://openalex.org/W3093606042, https://openalex.org/W3160254567, https://openalex.org/W4396623738, https://openalex.org/W2122744082, https://openalex.org/W2230943006, https://openalex.org/W4225493376, https://openalex.org/W2186062199, https://openalex.org/W2461719374, https://openalex.org/W2750423117, https://openalex.org/W4312680737 |
| cited_by_count | 18 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 5 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 10 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 3 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1016/j.berh.2022.101761 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S1036238847 |
| best_oa_location.source.issn | 1521-6942, 1532-1770 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1521-6942 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Best Practice & Research Clinical Rheumatology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_lineage_names | Elsevier BV |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Best Practice & Research Clinical Rheumatology |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.berh.2022.101761 |
| primary_location.id | doi:10.1016/j.berh.2022.101761 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S1036238847 |
| primary_location.source.issn | 1521-6942, 1532-1770 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1521-6942 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Best Practice & Research Clinical Rheumatology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_lineage_names | Elsevier BV |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Best Practice & Research Clinical Rheumatology |
| primary_location.landing_page_url | https://doi.org/10.1016/j.berh.2022.101761 |
| publication_date | 2022-06-01 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2068678719, https://openalex.org/W2016864201, https://openalex.org/W2054116014, https://openalex.org/W2114795284, https://openalex.org/W2143952074, https://openalex.org/W2144385565, https://openalex.org/W2108291386, https://openalex.org/W2023552718, https://openalex.org/W1982976664, https://openalex.org/W2064041290, https://openalex.org/W6656398272, https://openalex.org/W2124422230, https://openalex.org/W1967513322, https://openalex.org/W2120382078, https://openalex.org/W6712902827, https://openalex.org/W1969797389, https://openalex.org/W3008964791, https://openalex.org/W2164324047, https://openalex.org/W4220830783, https://openalex.org/W2992931934, https://openalex.org/W2159754384, https://openalex.org/W2105258856, https://openalex.org/W1993741004, https://openalex.org/W2561943186, https://openalex.org/W2509414269, https://openalex.org/W2567310363, https://openalex.org/W1987807233, https://openalex.org/W3115646653, https://openalex.org/W1968257316, https://openalex.org/W2883721603, https://openalex.org/W2601406675, https://openalex.org/W2169404909, https://openalex.org/W2162695817, https://openalex.org/W2795445824, https://openalex.org/W2578594284, https://openalex.org/W2080178849, https://openalex.org/W4295126505, https://openalex.org/W2981890331, https://openalex.org/W2082318350, https://openalex.org/W1558352705, https://openalex.org/W2032132148, https://openalex.org/W2059178471, https://openalex.org/W2010717729, https://openalex.org/W2254093789, https://openalex.org/W2013835020, https://openalex.org/W2962911524, https://openalex.org/W3087644999, https://openalex.org/W1986494833, https://openalex.org/W1995262612, https://openalex.org/W2793625589, https://openalex.org/W3198585565, https://openalex.org/W2169168471, https://openalex.org/W6680116387, https://openalex.org/W1980438889, https://openalex.org/W2041188420, https://openalex.org/W2582527364, https://openalex.org/W2287985949, https://openalex.org/W2169165927, https://openalex.org/W1982812572, https://openalex.org/W2058045094, https://openalex.org/W2137686155, https://openalex.org/W2046481438, https://openalex.org/W2076951127, https://openalex.org/W2014584314, https://openalex.org/W1649471366, https://openalex.org/W2016154801, https://openalex.org/W2046637170, https://openalex.org/W2084613639, https://openalex.org/W1916029359, https://openalex.org/W2161745696, https://openalex.org/W2805613838, https://openalex.org/W2014900505, https://openalex.org/W6676199798, https://openalex.org/W2600712227, https://openalex.org/W2114540123, https://openalex.org/W2060610804, https://openalex.org/W1976986089, https://openalex.org/W6785221381, https://openalex.org/W2140323371, https://openalex.org/W2056222248, https://openalex.org/W2077300798, https://openalex.org/W2156414024, https://openalex.org/W89028915, https://openalex.org/W2167017590, https://openalex.org/W2072335655, https://openalex.org/W3198276966, https://openalex.org/W6657049043, https://openalex.org/W2573386810, https://openalex.org/W2139140111, https://openalex.org/W3213307544, https://openalex.org/W2163276416, https://openalex.org/W2076277955, https://openalex.org/W6757452679, https://openalex.org/W2080549758, https://openalex.org/W2591693330, https://openalex.org/W2908684623, https://openalex.org/W3097710518, https://openalex.org/W2400143230, https://openalex.org/W1996779999, https://openalex.org/W2134406320, https://openalex.org/W2023155726, https://openalex.org/W2106861254 |
| referenced_works_count | 102 |
| abstract_inverted_index.T | 51 |
| abstract_inverted_index.a | 5, 16, 141 |
| abstract_inverted_index.an | 101 |
| abstract_inverted_index.as | 53, 55 |
| abstract_inverted_index.by | 48, 59 |
| abstract_inverted_index.in | 70, 76, 115 |
| abstract_inverted_index.is | 4, 100, 140 |
| abstract_inverted_index.it | 78 |
| abstract_inverted_index.of | 19, 40, 84, 96, 108, 129, 144 |
| abstract_inverted_index.to | 88, 104, 118 |
| abstract_inverted_index.we | 124 |
| abstract_inverted_index.IBM | 13, 41 |
| abstract_inverted_index.and | 24, 81, 94, 112, 135, 137 |
| abstract_inverted_index.how | 138 |
| abstract_inverted_index.new | 120 |
| abstract_inverted_index.our | 106 |
| abstract_inverted_index.the | 22, 72, 82, 85, 109, 126, 131 |
| abstract_inverted_index.IBM, | 77 |
| abstract_inverted_index.body | 1 |
| abstract_inverted_index.both | 145 |
| abstract_inverted_index.into | 64 |
| abstract_inverted_index.loss | 95 |
| abstract_inverted_index.need | 103 |
| abstract_inverted_index.over | 36 |
| abstract_inverted_index.some | 68 |
| abstract_inverted_index.this | 116 |
| abstract_inverted_index.well | 54 |
| abstract_inverted_index.with | 15 |
| abstract_inverted_index.(IBM) | 3 |
| abstract_inverted_index.Here, | 123 |
| abstract_inverted_index.leads | 87 |
| abstract_inverted_index.major | 142 |
| abstract_inverted_index.other | 29 |
| abstract_inverted_index.there | 99 |
| abstract_inverted_index.these | 146 |
| abstract_inverted_index.time. | 37 |
| abstract_inverted_index.ageing | 11, 139 |
| abstract_inverted_index.become | 34 |
| abstract_inverted_index.cells, | 52 |
| abstract_inverted_index.finger | 25 |
| abstract_inverted_index.flexor | 26 |
| abstract_inverted_index.highly | 49 |
| abstract_inverted_index.marked | 58 |
| abstract_inverted_index.muscle | 8 |
| abstract_inverted_index.slowly | 6 |
| abstract_inverted_index.urgent | 102 |
| abstract_inverted_index.Despite | 67 |
| abstract_inverted_index.between | 133 |
| abstract_inverted_index.bodies. | 66 |
| abstract_inverted_index.current | 127 |
| abstract_inverted_index.discuss | 125 |
| abstract_inverted_index.disease | 9, 86, 117 |
| abstract_inverted_index.improve | 105 |
| abstract_inverted_index.include | 42 |
| abstract_inverted_index.muscles | 30, 33 |
| abstract_inverted_index.pattern | 18 |
| abstract_inverted_index.protein | 61 |
| abstract_inverted_index.remains | 79 |
| abstract_inverted_index.affected | 35 |
| abstract_inverted_index.although | 28 |
| abstract_inverted_index.cellular | 73 |
| abstract_inverted_index.features | 57 |
| abstract_inverted_index.identify | 119 |
| abstract_inverted_index.involved | 75, 114 |
| abstract_inverted_index.muscles, | 27 |
| abstract_inverted_index.myositis | 2 |
| abstract_inverted_index.pathways | 74, 113 |
| abstract_inverted_index.presents | 14 |
| abstract_inverted_index.progress | 69 |
| abstract_inverted_index.targets. | 122 |
| abstract_inverted_index.weakness | 20 |
| abstract_inverted_index.Inclusion | 0 |
| abstract_inverted_index.affecting | 10 |
| abstract_inverted_index.features, | 44 |
| abstract_inverted_index.features. | 147 |
| abstract_inverted_index.hallmarks | 39 |
| abstract_inverted_index.including | 31, 45 |
| abstract_inverted_index.inclusion | 65 |
| abstract_inverted_index.involving | 21 |
| abstract_inverted_index.organised | 63 |
| abstract_inverted_index.treatment | 121 |
| abstract_inverted_index.weakness, | 90 |
| abstract_inverted_index.Therefore, | 98 |
| abstract_inverted_index.aggregates | 62 |
| abstract_inverted_index.autoimmune | 43 |
| abstract_inverted_index.dependency | 93 |
| abstract_inverted_index.endomysial | 46 |
| abstract_inverted_index.influencer | 143 |
| abstract_inverted_index.mechanisms | 111 |
| abstract_inverted_index.pharyngeal | 32 |
| abstract_inverted_index.quadriceps | 23 |
| abstract_inverted_index.underlying | 110 |
| abstract_inverted_index.wheelchair | 92 |
| abstract_inverted_index.disability, | 91 |
| abstract_inverted_index.distinctive | 17 |
| abstract_inverted_index.progression | 83 |
| abstract_inverted_index.progressive | 7, 89 |
| abstract_inverted_index.Pathological | 38 |
| abstract_inverted_index.autoimmunity | 134 |
| abstract_inverted_index.degenerative | 56 |
| abstract_inverted_index.individuals. | 12 |
| abstract_inverted_index.infiltration | 47 |
| abstract_inverted_index.untreatable, | 80 |
| abstract_inverted_index.degeneration, | 136 |
| abstract_inverted_index.independence. | 97 |
| abstract_inverted_index.intramyofibre | 60 |
| abstract_inverted_index.understanding | 71, 107, 128 |
| abstract_inverted_index.differentiated | 50 |
| abstract_inverted_index.interrelationship | 132 |
| abstract_inverted_index.aetiopathogenesis, | 130 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 96 |
| corresponding_author_ids | https://openalex.org/A5037255930, https://openalex.org/A5091086475 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I145311948, https://openalex.org/I176790772, https://openalex.org/I2799853436 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/10 |
| sustainable_development_goals[0].score | 0.699999988079071 |
| sustainable_development_goals[0].display_name | Reduced inequalities |
| citation_normalized_percentile.value | 0.91622028 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |